NCT02377193 - Simulect Versus ATG in Sensitized Renal Transplant Patient | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions

Renal Transplant Rejection

Interventions

DRUG

Simulect

"Simulect IV 40 mg/day D0 and D4~and oral use Tacrolimus 0.1 mg/ kg/ day + Myfortic 720 to 1440mg + Corticosteroids 5mg"

DRUG

ATG Fresenius

Simulect IV 40 mg/day D0 and D4 and oral use Tacrolimus 0.1 mg/ kg/ day + Myfortic 720 to 1440mg + Corticosteroids 5mg

Trial Locations (1)

UHToulouse, Toulouse